Based on a well-characterized single-center registry of patients with kidney stones, we report that RAS activity surveyed by the urinary excretion rate of metabolite tetrahydroaldosterone [14] is independently associated with circulating FGF23. Here, FGF23 is linked to nephrolithiasis.